As the world battles the COVID-19 pandemic, the White House has warned time and time again that a vaccine for the SARS-CoV-2 virus won’t be available for another 12 to 18 months.
In a crisis, that sounds like forever.
>>> When can America reopen? The National Coronavirus Recovery Commission, a project of The Heritage Foundation, is gathering America’s top thinkers together to figure that out. Learn more here.
In the 2011 movie “Contagion,” the valiant researchers at the Centers for Disease Control and Prevention manage to discover the cause of the disease, develop the vaccine, and, by Day 131, start inoculating Americans.
So, why can’t we do the same?
It turns out that the real world is more challenging. Vaccine development is a complex, multistep process that includes rigorous clinical testing and regulatory hurdles.
Throughout the vaccine development process, scientists, policymakers, and government regulators must constantly walk the tightrope between speed, efficacy, and product safety to produce a vaccine that creates a neutralizing immune response to the virus.
With that in mind, let’s take a look at the process.
More
DelMarVa's Premier Source for News, Opinion, Analysis, and Human Interest Contact Publisher Joe Albero at alberobutzo@wmconnect.com or 410-430-5349
No comments:
Post a Comment